PMID- 29310728 OWN - NLM STAT- MEDLINE DCOM- 20181005 LR - 20221207 IS - 1601-5215 (Electronic) IS - 0924-2708 (Linking) VI - 30 IP - 3 DP - 2018 Jun TI - BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression. PG - 168-174 LID - 10.1017/neu.2017.37 [doi] AB - OBJECTIVE: We investigated the separate effects of and possible interactions between the functional polymorphisms of brain-derived neurotrophic factor (BDNF) rs11030101, BDNF rs61888800, and neuregulin-1 (NRG1) rs3924999 and NRG1 rs6994992 on change of temperament scores in a clinical sample of subjects with major depression (MDD), who received selective serotonin reuptake inhibitor treatment for a period of 6 weeks. METHODS: The study population consisted of 98 Finnish individuals with MDD. They were assessed by the 107-item Temperament and Character Inventory temperament questionnaire (version IX) and the Montgomery-Asberg Depression Rating Scale (MADRS). In general linear univariate models (GLM) for novelty seeking (NS) or reward dependence (RD) change age, gender, MADRS score change and BDNF and NRG1 genotypes were used as explaining explanatory variables. RESULTS: Mean comparisons between corresponding temperament dimensions and genotypes showed significant differences between NS change and BDNF rs61888800 T-carrying status (mean difference: GG 0.30, GT/TT 2.47, p=0.022, t-test) and between RD change and NRG1 rs3924999 A-carrying status (mean difference: GG 1.21, GA/AA -0.33, p=0.003). In GLM models for NS change the significant predictors comprised BDNF rs61888800 T-carrying status, age and MADRS score change (model 1), and additionally NRG1 rs6994992 T-carrying status (model 2). For RD change the predictors included NRG1 rs3924999 A-carrying status, age and MADRS score change (model 1) and additionally gender (model 2). CONCLUSION: According to the current results both BDNF and NRG1 are associated with temperament traits during depression. These results warrant further studies regarding the impact of this association on depression recovery. FAU - Andre, Kadri AU - Andre K AD - 1Faculty of Medicine and Life Sciences,University of Tampere,Tampere,Finland. FAU - Kampman, Olli AU - Kampman O AD - 1Faculty of Medicine and Life Sciences,University of Tampere,Tampere,Finland. FAU - Viikki, Merja AU - Viikki M AD - 1Faculty of Medicine and Life Sciences,University of Tampere,Tampere,Finland. FAU - Setala-Soikkeli, Eija AU - Setala-Soikkeli E AD - 4Department of Psychiatry,Kanta-Hame Hospital District,Hameenlinna,Finland. FAU - Illi, Ari AU - Illi A AD - 1Faculty of Medicine and Life Sciences,University of Tampere,Tampere,Finland. FAU - Mononen, Nina AU - Mononen N AD - 1Faculty of Medicine and Life Sciences,University of Tampere,Tampere,Finland. FAU - Lehtimaki, Terho AU - Lehtimaki T AD - 1Faculty of Medicine and Life Sciences,University of Tampere,Tampere,Finland. FAU - Leinonen, Esa AU - Leinonen E AD - 1Faculty of Medicine and Life Sciences,University of Tampere,Tampere,Finland. LA - eng PT - Journal Article DEP - 20180109 PL - England TA - Acta Neuropsychiatr JT - Acta neuropsychiatrica JID - 9612501 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (NRG1 protein, human) RN - 0 (Neuregulin-1) RN - 0 (Serotonin Uptake Inhibitors) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Adult MH - Brain-Derived Neurotrophic Factor/*genetics MH - *Depressive Disorder, Major/drug therapy/genetics/physiopathology MH - *Exploratory Behavior/drug effects/physiology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Neuregulin-1/*genetics MH - Personality Assessment MH - Psychiatric Status Rating Scales MH - *Reward MH - Selective Serotonin Reuptake Inhibitors/administration & dosage/*pharmacology MH - *Temperament/drug effects/physiology OTO - NOTNLM OT - brain-derived neurotrophic factor OT - depression OT - neuregulin-1 OT - temperament EDAT- 2018/01/10 06:00 MHDA- 2018/10/06 06:00 CRDT- 2018/01/10 06:00 PHST- 2018/01/10 06:00 [pubmed] PHST- 2018/10/06 06:00 [medline] PHST- 2018/01/10 06:00 [entrez] AID - S0924270817000370 [pii] AID - 10.1017/neu.2017.37 [doi] PST - ppublish SO - Acta Neuropsychiatr. 2018 Jun;30(3):168-174. doi: 10.1017/neu.2017.37. Epub 2018 Jan 9.